Acute myeloid leukemia (AML) is a serious haematological malignancy requiring prompt, structured clinical management. This page outlines the framework for a first-line evidence-based protocol; the complete regimen is available through the link below.
This protocol addresses first-line management of Acute myeloid leukemia. The full structured regimen — including clinical decision points, sequencing, and evidence-based options — is accessible through the full protocol.